Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.

Natarajan K, Prasad N, Dascomb K, Irving SA, Yang DH, Gaglani M, Klein NP, DeSilva MB, Ong TC, Grannis SJ, Stenehjem E, Link-Gelles R, Rowley EA, Naleway AL, Han J, Raiyani C, Benitez GV, Rao S, Lewis N, Fadel WF, Grisel N, Griggs EP, Dunne MM, Stockwell MS, Mamawala M, McEvoy C, Barron MA, Goddard K, Valvi NR, Arndorfer J, Patel P, Mitchell PK, Smith M, Kharbanda AB, Fireman B, Embi PJ, Dickerson M, Davis JM, Zerbo O, Dalton AF, Wondimu MH, Azziz-Baumgartner E, Bozio CH, Reynolds S, Ferdinands J, Williams J, Schrag SJ, Verani JR, Ball S, Thompson MG, Dixon BE

Open source

DOI
10.15585/mmwr.mm7113e2
Published
2022 Apr 1
Container
MMWR. Morbidity and mortality weekly report
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15585/mmwr.mm7113e2,
  title = {Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson \& Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.},
  author = {Natarajan K and Prasad N and Dascomb K and Irving SA and Yang DH and Gaglani M and Klein NP and DeSilva MB and Ong TC and Grannis SJ and Stenehjem E and Link-Gelles R and Rowley EA and Naleway AL and Han J and Raiyani C and Benitez GV and Rao S and Lewis N and Fadel WF and Grisel N and Griggs EP and Dunne MM and Stockwell MS and Mamawala M and McEvoy C and Barron MA and Goddard K and Valvi NR and Arndorfer J and Patel P and Mitchell PK and Smith M and Kharbanda AB and Fireman B and Embi PJ and Dickerson M and Davis JM and Zerbo O and Dalton AF and Wondimu MH and Azziz-Baumgartner E and Bozio CH and Reynolds S and Ferdinands J and Williams J and Schrag SJ and Verani JR and Ball S and Thompson MG and Dixon BE},
  year = {2022},
  journal = {MMWR. Morbidity and mortality weekly report},
  doi = {10.15585/mmwr.mm7113e2},
  url = {https://doi.org/10.15585/mmwr.mm7113e2}
}

RIS

TY  - JOUR
TI  - Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
AU  - Natarajan K
AU  - Prasad N
AU  - Dascomb K
AU  - Irving SA
AU  - Yang DH
AU  - Gaglani M
AU  - Klein NP
AU  - DeSilva MB
AU  - Ong TC
AU  - Grannis SJ
AU  - Stenehjem E
AU  - Link-Gelles R
AU  - Rowley EA
AU  - Naleway AL
AU  - Han J
AU  - Raiyani C
AU  - Benitez GV
AU  - Rao S
AU  - Lewis N
AU  - Fadel WF
AU  - Grisel N
AU  - Griggs EP
AU  - Dunne MM
AU  - Stockwell MS
AU  - Mamawala M
AU  - McEvoy C
AU  - Barron MA
AU  - Goddard K
AU  - Valvi NR
AU  - Arndorfer J
AU  - Patel P
AU  - Mitchell PK
AU  - Smith M
AU  - Kharbanda AB
AU  - Fireman B
AU  - Embi PJ
AU  - Dickerson M
AU  - Davis JM
AU  - Zerbo O
AU  - Dalton AF
AU  - Wondimu MH
AU  - Azziz-Baumgartner E
AU  - Bozio CH
AU  - Reynolds S
AU  - Ferdinands J
AU  - Williams J
AU  - Schrag SJ
AU  - Verani JR
AU  - Ball S
AU  - Thompson MG
AU  - Dixon BE
PY  - 2022
JO  - MMWR. Morbidity and mortality weekly report
DO  - 10.15585/mmwr.mm7113e2
UR  - https://doi.org/10.15585/mmwr.mm7113e2
ER  - 

APA

K, N., N, P., K, D., SA, I., DH, Y., M, G., NP, K., MB, D., TC, O., SJ, G., E, S., R, L., EA, R., AL, N., J, H., C, R., GV, B., S, R., N, L., WF, F., N, G., EP, G., MM, D., MS, S., M, M., C, M., MA, B., K, G., NR, V., J, A., P, P., PK, M., M, S., AB, K., B, F., PJ, E., M, D., JM, D., O, Z., AF, D., MH, W., E, A., CH, B., S, R., J, F., J, W., SJ, S., JR, V., S, B., MG, T., & BE, D. (2022). Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.. MMWR. Morbidity and mortality weekly report. https://doi.org/10.15585/mmwr.mm7113e2

Source records